SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Yang Michael J. – ‘4’ for 1/15/24 re: Ionis Pharmaceuticals Inc.

On:  Wednesday, 1/17/24, at 8:50pm ET   ·   For:  1/15/24   ·   As:  Director   ·   Accession #:  874015-24-57   ·   File #:  0-19125

Previous ‘4’:  ‘4’ on 12/18/23 for 12/14/23   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/17/24  Yang Michael J.                   4          Director    1:5K   Ionis Pharmaceuticals Inc.        Ionis Pharmas Inc.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      6K 
                Securities by an Insider -- edgardoc.xml/5.8                     




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  1/15/24
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  874015
Issuer Name:  IONIS PHARMACEUTICALS INC
Issuer Trading Symbol:  IONS
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1702283
Owner Name:  YANG MICHAEL J.
Reporting Owner Address:
Owner Street 1:  2855 GAZELLE COURT
Owner Street 2:
Owner City:  CARLSBAD
Owner State:  CA
Owner ZIP Code:  92010
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Aff 10b5 One:  0
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Restricted Stock Unit
Conversion or Exercise Price:
Value:  0.0
Footnote ID:  F1
Transaction Date:
Value:  1/15/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  A
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  5,791
Transaction Price Per Share:
Value:  0.0
Transaction Acquired-Disposed Code:
Value:  A
Exercise Date:
Footnote ID:  F2
Expiration Date:
Footnote ID:  F2
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  5,791
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  5,791
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Footnote - F2Grant on January 15, 2024 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on January 15, 2025. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2027. The RSU is vested as to 0 shares on January 15, 2024.
Owner Signature:
Signature Name:  By: Patrick R. O'Neil, attorney-in-fact For: Michael J. Yang
Signature Date:  1/17/24


Top
Filing Submission 0000874015-24-000057   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 11:50:16.1am ET